ALS Information for Patients and Caregivers
What are Rilutek tablets?
Rilutek is the first effective treatment for people with ALS. Laboratory studies
suggest that Rilutek is “neuroprotective,” which means it protects nerve cells from
damage. Many researchers believe that Rilutek protects the nerve cells by what they
describe as “glutamate (pronounced glue-tah-mate) inhibition.” Researchers also
believe that this activity could explain the effect Rilutek has on the survival
of people with ALS.
The human body naturally produces glutamate, which carries signals to the motor
neurons. This is one link in the chain of how the brain tells the muscles what to
do. One of several theories researchers have is that in people with ALS, parts of
the nervous system are overexposed to glutamate. A buildup of glutamate has been
seen early in the progression of this disease. Too much glutamate “burns out” the
motor neurons so that they can’t carry the brain’s messages to the muscles to tell
them what to do.
The active ingredient in Rilutek is riluzole (pronounced rill-you-zole). Sanofi-aventis
is the company that distributes Rilutek.